Marcie A. Goldstein

Davis Polk advised the underwriter in connection with a secondary offering of 12,000,000 American Depositary Shares of Hutchison China Meditech Limited (“Chi-Med”), each representing five…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the SEC-registered offering by Fiserv, Inc. of €500 million principal amount of…

Davis Polk advised the underwriters in connection with the $35 million SEC-registered follow-on offering of ordinary shares of Gamida Cell Ltd. The ordinary shares are listed on the Nasdaq…

Davis Polk advised the representatives of the several underwriters in connection with the $125 million initial public offering of common stock by Atreca, Inc. The common stock is listed on…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the SEC-registered offering by Fiserv, Inc. of $2 billion principal amount of 2…

Davis Polk advised the underwriters in connection with the $435 million initial public offering of common stock by Grocery Outlet Holding Corp. The common stock is listed on The Nasdaq…

Davis Polk advised the joint book-running managers and representatives of the several underwriters on the $155 million initial public offering by Personalis, Inc. The common stock is listed…

Davis Polk advised the representatives of the underwriters in connection with the $163.3 million initial public offering of 9,074,776 shares of common stock of Stoke Therapeutics, Inc.,…

Davis Polk advised the underwriters in connection with the $1.2 billion initial public offering of 53,475,000 shares of Class A common stock of Chewy, Inc., of which 5,600,000 shares were…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the approximately $128 million follow-on offering by Orchard Therapeutics…